Forge Medical is a United States-based startup that is revolutionizing the future of radial and tibial/pedal arterial hemostasis. Established in 2009, Forge Medical has developed the VasoStat® Hemostasis Device, which has received FDA clearance for use on radial, distal radial, and tibial/pedal access sites. The innovative nature of Forge Medical's product has attracted the attention of investors, with the Life Sciences Angel Network participating in the company's $180.00K Seed Round investment on 02 November 2011. The company operates within the hardware industry, presenting a promising opportunity for venture capital firms seeking investment prospects in the medical technology space. With its unique offering and successful track record, Forge Medical demonstrates potential for growth and impact in the healthcare sector.
No recent news or press coverage available for Forge Medical.